Cargando…

High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer

BACKGROUND: We previously showed that α3β1 integrin is a novel cancer biomarker and drug target in non-small cell lung cancer (NSCLC). This study characterized the integrin α3 (ITGA3) expression on patient specimens. METHODS: Tissue microarrays (TMAs) were prepared from archival tissue blocks contai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qianping, Ma, Weijie, Chen, Shuai, Tian, Eddie C., Wei, Sixi, Fan, Reggie R., Wang, Tao, Zhou, Chihong, Li, Tianhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481578/ https://www.ncbi.nlm.nih.gov/pubmed/32953510 http://dx.doi.org/10.21037/tlcr-19-633

Ejemplares similares

High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer
por: Xiao, Wenwu, et al.
Publicado: (2019)

Correction to: High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer
por: Xiao, Wenwu, et al.
Publicado: (2019)

Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer
por: Ma, Weijie, et al.
Publicado: (2023)

Integrin α6 Indicates a Poor Prognosis of Craniopharyngioma through Bioinformatic Analysis and Experimental Validation
por: Jia, Yanfei, et al.
Publicado: (2022)

Enhanced expression of cohesin loading factor NIPBL confers poor prognosis and chemotherapy resistance in non-small cell lung cancer
por: Xu, Weizhen, et al.
Publicado: (2015)

Integrin α4 Enhances Metastasis and May Be Associated with Poor Prognosis in MYCN(low) Neuroblastoma
por: Young, Shanique A., et al.
Publicado: (2015)

MARCH8 is associated with poor prognosis in non-small cell lung cancers patients
por: Fan, Jiye, et al.
Publicado: (2017)

Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry
por: Ma, Weijie, et al.
Publicado: (2023)

Correlation of neuroendocrine features with prognosis of non-small cell lung cancer
por: Feng, Jianguo, et al.
Publicado: (2016)

Hospitalized cancer patients with comorbidities and low lymphocyte counts had poor clinical outcomes to immune checkpoint inhibitors
por: Young, Richard Benjamin, et al.
Publicado: (2022)

Integrin α3/α6 and αV are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression
por: Zhou, Jieqi, et al.
Publicado: (2022)

Overexpression of β1 integrin contributes to polarity reversal and a poor prognosis of breast invasive micropapillary carcinoma
por: Liu, Bingbing, et al.
Publicado: (2017)

High Expression of Plasma Extracellular HSP90α is Associated With the Poor Efficacy of Chemotherapy and Prognosis in Small Cell Lung Cancer
por: Huang, Baoyue, et al.
Publicado: (2022)

Low claudin-6 expression correlates with poor prognosis in patients with non-small cell lung cancer
por: Wang, Qiang, et al.
Publicado: (2015)

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer()
por: Zhu, Jinhong, et al.
Publicado: (2016)

Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma
por: Fan, Zhengyang, et al.
Publicado: (2023)

Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer
por: Zhu, Bojin, et al.
Publicado: (2018)

CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer
por: Si, Jiahui, et al.
Publicado: (2017)

Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis
por: Wang, Kaiyuan, et al.
Publicado: (2019)

Downregulation of ARID1A is correlated with poor prognosis in non-small cell lung cancer
por: Wang, Tao, et al.
Publicado: (2020)

Co-expression of PD-L1 and HIF-1α predicts poor prognosis in Patients with Non-small Cell Lung Cancer after surgery
por: Zheng, Hongmei, et al.
Publicado: (2021)

GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer
por: Feng, Yong, et al.
Publicado: (2022)

Association of BTBD7 with Metastasis and Poor Prognosis in Non-Small-Cell Lung Cancer Patients
por: Luo, Fan-Yan, et al.
Publicado: (2015)

PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer
por: Fu, Xiao, et al.
Publicado: (2020)

Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer
por: Kong, Peng-Zhou, et al.
Publicado: (2016)

Effect of Adjuvant Magnetic Fields in Radiotherapy on Non-Small-Cell Lung Cancer Cells In Vitro
por: Feng, Jianguo, et al.
Publicado: (2013)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
por: HONG, LING-ZHI, et al.
Publicado: (2013)

M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer
por: Cao, Lili, et al.
Publicado: (2019)

LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity
por: Zeltz, Cédric, et al.
Publicado: (2019)

Integrin α11 in non–small cell lung cancer is associated with tumor progression and postoperative recurrence
por: Ando, Takahiro, et al.
Publicado: (2019)

Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer
por: Li, Yunxia, et al.
Publicado: (2018)

Activation of Janus kinase 1 confers poor prognosis in patients with non-small cell lung cancer
por: Liu, Dan, et al.
Publicado: (2017)

The novel lncRNA PTTG3P is downregulated and predicts poor prognosis in non-small cell lung cancer
por: Huang, Hai-Tao, et al.
Publicado: (2020)

Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer
por: Tian, Yubin, et al.
Publicado: (2022)

Decreased Expression of PACSIN1 in Brain Glioma Samples Predicts Poor Prognosis
por: Zimu, Zhou, et al.
Publicado: (2021)

Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer
por: Liu, Fayong, et al.
Publicado: (2021)

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
por: Li, Zhenling, et al.
Publicado: (2015)

High CEP55 expression is associated with poor prognosis in non-small-cell lung cancer
por: Jiang, Chao, et al.
Publicado: (2018)

Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis
por: Wang, Zhao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vst9bl0e5q73e5cohgcjqf7vnn